Rafferty Asset Management, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1389426 New York, NY

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,773,203

-$765,967 QoQ

Shares Held

36,232

-7.2% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Rafferty Asset Management, LLC holds $27,399,554 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	162,424	$5,743,312
2	UTHR	UNITED THERAPEUTICS Corp	8,887	$5,269,813
3	NBIX	Neurocrine Biosciences Inc This page	36,232	$4,773,203
4	ZTS	Zoetis Inc.	33,846	$4,000,935
5	BCRX	Biocryst Pharmaceuticals Inc	354,260	$3,372,555
6	VTRS	Viatris Inc	99,502	$1,344,272
7	IRWD	Ironwood Pharmaceuticals Inc	216,623	$760,346
8	EBS	Emergent BioSolutions Inc.	85,199	$707,151

All Filings in NBIX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,773,203	36,232	-7.2%	Shares	Sole	2026-05-15
2025-12-31	$5,539,170	39,055	-33.5%	Shares	Sole	2026-02-13
2025-09-30	$8,240,446	58,701	-25.8%	Shares	Sole	2025-11-12
2025-06-30	$9,947,860	79,146	-21.5%	Shares	Sole	2025-08-14
2025-03-31	$11,149,254	100,807	-5.8%	Shares	Sole	2025-05-14
2024-12-31	$14,607,001	107,011	-24.0%	Shares	Sole	2025-02-14
2024-09-30	$16,227,008	140,835	+14.5%	Shares	Sole	2024-11-13
2024-06-30	$16,933,134	122,998	+86.7%	Shares	Sole	2024-08-13
2024-03-31	$9,084,790	65,870	-14.0%	Shares	Sole	2024-05-13
2023-12-31	$10,086,096	76,549	-6.1%	Shares	Sole	2024-02-13
2023-09-30	$9,167,625	81,490	-8.5%	Shares	Sole	2023-11-13
2023-06-30	$8,395,623	89,031	+25.4%	Shares	Sole	2023-08-11
2023-03-31	$7,185,405	70,988	+3.4%	Shares	Sole	2023-05-11
2022-12-31	$8,200,033	68,654	+5.4%	Shares	Sole	2023-02-13
2022-09-30	$6,917,351	65,129	+61.2%	Shares	Sole	2022-11-14
2022-06-30	$3,938,386	40,402	-32.5%	Shares	Sole	2022-08-12
2022-03-31	$5,615,250	59,896	-9.5%	Shares	Sole	2022-05-13
2021-12-31	$5,638,254	66,200	+105.5%	Shares	Sole	2022-02-10
2021-09-30	$3,089,644	32,214	+21.8%	Shares	Sole	2021-11-10
2021-06-30	$2,574,114	26,450	-23.0%	Shares	Sole	2021-08-10
2021-03-31	$3,339,176	34,336	+232.3%	Shares	Sole	2021-05-10
2020-12-31	$990,513	10,334	-47.7%	Shares	Sole	2021-02-10
2020-09-30	$1,900,698	19,766	+77.4%	Shares	Sole	2020-11-13
2020-06-30	$1,359,690	11,145	+160.3%	Shares	Sole	2020-08-07
2020-03-31	$370,520	4,281	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.